Abbott Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Abbott Laboratories
ABT Stock  USD 113.10  0.51  0.45%   
Analyzing historical trends in various income statement and balance sheet accounts from Abbott Laboratories' financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Abbott Laboratories' valuation are summarized below:
Gross Profit
25.1 B
Profit Margin
0.1472
Market Capitalization
197.4 B
Enterprise Value Revenue
4.5846
Revenue
44.3 B
There are currently one hundred twenty fundamental signals for Abbott Laboratories that can be evaluated and compared over time across rivals. All traders should validate Abbott Laboratories' prevailing fundamentals against the performance from 2010 to 2026 and make sure the trends continue to evolve in the right direction. Market Cap is likely to gain to about 180.4 B in 2026. Enterprise Value is likely to gain to about 188.9 B in 2026

Abbott Laboratories Total Revenue

23.39 Billion

Check Abbott Laboratories financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Abbott Laboratories' main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.7 B, Interest Expense of 323.9 M or Selling General Administrative of 6.6 B, as well as many indicators such as Price To Sales Ratio of 5.18, Dividend Yield of 0.0179 or PTB Ratio of 2.65. Abbott financial statements analysis is a perfect complement when working with Abbott Laboratories Valuation or Volatility modules.
  
Build AI portfolio with Abbott Stock
Check out the analysis of Abbott Laboratories Correlation against competitors.
For more information on how to buy Abbott Stock please use our How to Invest in Abbott Laboratories guide.

Abbott Laboratories Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets91 B86.7 B63.7 B
Slightly volatile
Short and Long Term Debt Total10.1 B15.1 B15.4 B
Slightly volatile
Other Current Liabilities8.8 B8.4 B6.4 B
Slightly volatile
Total Current Liabilities8.7 B16.5 B11.1 B
Slightly volatile
Total Stockholder Equity54.7 B52.1 B31.3 B
Slightly volatile
Property Plant And Equipment Net6.7 B12.9 B8.1 B
Slightly volatile
Net Debt6.1 B6.5 B8.3 B
Pretty Stable
Retained Earnings52.3 B49.8 B29.3 B
Slightly volatile
Cash8.9 B8.5 B7.3 B
Pretty Stable
Non Current Assets Total63.8 B60.7 B43.1 B
Slightly volatile
Non Currrent Assets Other18.2 B17.3 B5.3 B
Slightly volatile
Cash And Short Term Investments4.6 B8.9 B8 B
Very volatile
Net Receivables4.1 B7.9 B5.3 B
Slightly volatile
Common Stock Shares Outstanding1.3 B1.7 B1.7 B
Very volatile
Liabilities And Stockholders Equity91 B86.7 B63.7 B
Slightly volatile
Non Current Liabilities Total12.3 B17.4 B20.2 B
Pretty Stable
Inventory6.8 B6.5 B4.2 B
Slightly volatile
Other Current Assets2.4 B2.6 B2.5 B
Pretty Stable
Total Liabilities20.8 B33.9 B30.8 B
Slightly volatile
Property Plant And Equipment Gross26.5 B25.2 B12.3 B
Slightly volatile
Total Current Assets14 B26 B19.9 B
Pretty Stable
Short Term Debt2.1 B3.3 B1.9 B
Pretty Stable
Accounts Payable4.5 B4.2 B2.8 B
Slightly volatile
Current Deferred Revenue148.8 M156.6 M301.8 M
Slightly volatile
Common Stock Total Equity29.8 B28.4 B19 B
Slightly volatile
Short Term Investments736.9 M417 M923.2 M
Slightly volatile
Common Stock26.8 B25.5 B18.7 B
Slightly volatile
Intangible Assets8.5 B5.5 B9.8 B
Pretty Stable
Other Liabilities5.7 B7.6 B6.5 B
Slightly volatile
Other Assets18.6 B17.7 B5.6 B
Slightly volatile
Long Term Debt12 B9.9 B13.3 B
Slightly volatile
Property Plant Equipment8.1 B13.5 B8.2 B
Slightly volatile
Good Will16.4 B24 B17.6 B
Slightly volatile
Noncontrolling Interest In Consolidated Entity163.8 M251.8 M167.7 M
Slightly volatile
Retained Earnings Total Equity27.2 B40.5 B27.4 B
Slightly volatile
Long Term Debt Total15.6 B14.5 B14.4 B
Slightly volatile
Long Term Investments1.1 B918 M1.1 B
Very volatile
Non Current Liabilities Other4.1 B2.5 B4.9 B
Slightly volatile
Short and Long Term Debt3.2 B3 B1.1 B
Slightly volatile
Cash And Equivalents6.8 B6.9 B11.9 B
Slightly volatile
Net Invested Capital60.8 B65.1 B57 B
Very volatile
Net Working Capital9.6 B9.5 B9.8 B
Slightly volatile
Capital Stock27 B25.5 B24.2 B
Slightly volatile
Capital Lease Obligations995 M931 M830.7 M
Slightly volatile

Abbott Laboratories Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization1.7 B2.7 B2.5 B
Slightly volatile
Selling General Administrative6.6 B12.4 B9.1 B
Slightly volatile
Total Revenue23.4 B44.3 B31 B
Slightly volatile
Gross Profit12.3 B24.6 B15.6 B
Slightly volatile
Other Operating Expenses18.6 B36.3 B25 B
Slightly volatile
Operating Income4.1 B8 B4.7 B
Slightly volatile
EBIT9.2 B8.8 B5 B
Slightly volatile
EBITDA5.8 B11.6 B7.2 B
Slightly volatile
Cost Of Revenue10.5 B19.7 B14.1 B
Slightly volatile
Total Operating Expenses17.4 B16.6 B11.5 B
Slightly volatile
Income Before Tax8.9 B8.5 B4.9 B
Slightly volatile
Net Income3.5 B6.5 B4.5 B
Slightly volatile
Research Development2.2 B3 B2.2 B
Slightly volatile
Net Income Applicable To Common Shares4.6 B6.5 B4.7 B
Slightly volatile
Minority Interest264.4 M251.8 M151.4 M
Slightly volatile
Selling And Marketing Expenses476.3 K569.2 K493.7 K
Pretty Stable
Net Income From Continuing Ops5.1 B6.5 B4.7 B
Slightly volatile
Non Recurring397 M331.2 M312.6 M
Very volatile
Discontinued Operations20.5 M21.6 M312.5 M
Slightly volatile
Interest Income268 M135 M183.7 M
Slightly volatile
Reconciled Depreciation2.3 B3.1 B2.9 B
Slightly volatile

Abbott Laboratories Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Free Cash Flow4.1 B7.4 B4.9 B
Slightly volatile
Begin Period Cash Flow4.1 B7.6 B6.8 B
Pretty Stable
Depreciation1.9 B3.1 B2.5 B
Slightly volatile
Capital Expenditures1.3 B2.2 B1.5 B
Slightly volatile
Total Cash From Operating Activities5.4 B9.6 B6.4 B
Slightly volatile
Net Income3.7 B6.5 B4.3 B
Slightly volatile
End Period Cash Flow4.3 B8.5 B7 B
Pretty Stable
Stock Based Compensation388.1 M664 M445.9 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio5.184.93783.728
Slightly volatile
Dividend Yield0.01790.01880.0238
Slightly volatile
PTB Ratio2.654.19883.72
Slightly volatile
Days Sales Outstanding49.8465.28862.1113
Slightly volatile
Book Value Per Share31.7230.206618.9975
Slightly volatile
Free Cash Flow Yield0.03210.03380.0511
Slightly volatile
Operating Cash Flow Per Share5.755.47573.9649
Slightly volatile
Stock Based Compensation To Revenue0.00860.0150.0131
Slightly volatile
Capex To Depreciation1.060.69670.7142
Pretty Stable
PB Ratio2.654.19883.72
Slightly volatile
EV To Sales5.345.08543.9839
Slightly volatile
Free Cash Flow Per Share4.444.2333.0146
Slightly volatile
ROIC0.150.08430.084
Pretty Stable
Inventory Turnover2.923.03963.5416
Slightly volatile
Net Income Per Share3.923.73442.7677
Slightly volatile
Days Of Inventory On Hand111120104
Slightly volatile
Payables Turnover7.284.65126.375
Slightly volatile
Sales General And Administrative To Revenue0.220.250.2939
Slightly volatile
Research And Ddevelopement To Revenue0.09230.06670.0722
Pretty Stable
Capex To Revenue0.07070.0490.0539
Pretty Stable
Cash Per Share5.375.11685.0108
Very volatile
POCF Ratio24.0322.881218.8702
Slightly volatile
Interest Coverage21.5223.601222.5888
Slightly volatile
Payout Ratio0.450.63090.7339
Very volatile
Capex To Operating Cash Flow0.350.22690.2816
Slightly volatile
PFCF Ratio31.0829.598626.1702
Slightly volatile
Days Payables Outstanding47.8678.474761.8919
Slightly volatile
Income Quality1.441.46632.1837
Very volatile
ROE0.120.12510.1506
Very volatile
EV To Operating Cash Flow24.7423.565420.166
Slightly volatile
PE Ratio17.3533.550237.7679
Very volatile
Return On Tangible Assets0.170.11420.1283
Slightly volatile
EV To Free Cash Flow15.8830.483726.9964
Slightly volatile
Earnings Yield0.02830.02980.0484
Slightly volatile
Intangibles To Total Assets0.290.34090.4053
Pretty Stable
Net Debt To EBITDA0.750.56651.2083
Pretty Stable
Current Ratio1.241.57591.8651
Slightly volatile
Receivables Turnover6.55.59065.8877
Slightly volatile
Graham Number52.5850.072532.9911
Slightly volatile
Shareholders Equity Per Share31.3329.839718.5665
Slightly volatile
Debt To Equity0.40.2890.5314
Pretty Stable
Capex Per Share0.661.24270.9121
Slightly volatile
Revenue Per Share26.6425.373819.2128
Slightly volatile
Interest Debt Per Share7.598.81979.5621
Pretty Stable
Debt To Assets0.180.17380.2428
Pretty Stable
Enterprise Value Over EBITDA20.4919.512417.3716
Slightly volatile
Short Term Coverage Ratios3.182.89096.1673
Pretty Stable
Price Earnings Ratio17.3533.550237.7679
Very volatile
Operating Cycle131185164
Pretty Stable
Price Book Value Ratio2.654.19883.72
Slightly volatile
Days Of Payables Outstanding47.8678.474761.8919
Slightly volatile
Dividend Payout Ratio0.450.63090.7339
Very volatile
Price To Operating Cash Flows Ratio24.0322.881218.8702
Slightly volatile
Price To Free Cash Flows Ratio31.0829.598626.1702
Slightly volatile
Pretax Profit Margin0.210.1910.1484
Slightly volatile
Ebt Per Ebit0.821.05191.053
Pretty Stable
Operating Profit Margin0.210.18160.1531
Slightly volatile
Company Equity Multiplier1.721.66342.089
Slightly volatile
Long Term Debt To Capitalization0.180.1720.288
Pretty Stable
Total Debt To Capitalization0.260.22420.333
Pretty Stable
Return On Capital Employed0.110.11460.1033
Pretty Stable
Debt Equity Ratio0.40.2890.5314
Pretty Stable
Ebit Per Revenue0.210.18160.1531
Slightly volatile
Quick Ratio0.971.18261.4957
Slightly volatile
Dividend Paid And Capex Coverage Ratio1.881.52161.6192
Pretty Stable
Net Income Per E B T0.650.77060.9161
Very volatile
Cash Ratio0.310.51660.68
Pretty Stable
Cash Conversion Cycle121107107
Slightly volatile
Operating Cash Flow Sales Ratio0.230.21580.2
Slightly volatile
Days Of Inventory Outstanding111120104
Slightly volatile
Days Of Sales Outstanding49.8465.28862.1113
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.540.77310.7119
Pretty Stable
Cash Flow Coverage Ratios0.90.63490.5593
Pretty Stable
Price To Book Ratio2.654.19883.72
Slightly volatile
Fixed Asset Turnover2.623.42513.7037
Pretty Stable
Capital Expenditure Coverage Ratio2.994.40633.9456
Pretty Stable
Price Cash Flow Ratio24.0322.881218.8702
Slightly volatile
Enterprise Value Multiple20.4919.512417.3716
Slightly volatile
Debt Ratio0.180.17380.2428
Pretty Stable
Cash Flow To Debt Ratio0.90.63490.5593
Pretty Stable
Price Sales Ratio5.184.93783.728
Slightly volatile
Return On Assets0.120.07520.0778
Pretty Stable
Asset Turnover0.830.51120.5497
Very volatile
Net Profit Margin0.170.14720.1392
Slightly volatile
Gross Profit Margin0.590.55510.511
Slightly volatile
Price Fair Value2.654.19883.72
Slightly volatile
Return On Equity0.120.12510.1506
Very volatile

Abbott Laboratories Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap180.4 B171.8 B132.2 B
Slightly volatile
Enterprise Value188.9 B179.9 B140.4 B
Slightly volatile

Abbott Fundamental Market Drivers

Forward Price Earnings20.0803
Cash And Short Term Investments8.9 B

Abbott Upcoming Events

17th of April 2024
Upcoming Quarterly Report
View
18th of July 2024
Next Financial Report
View
31st of March 2024
Next Fiscal Quarter End
View
22nd of January 2025
Next Fiscal Year End
View
31st of December 2023
Last Quarter Report
View
31st of December 2023
Last Financial Announcement
View

About Abbott Laboratories Financial Statements

Abbott Laboratories shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Abbott Laboratories investors may analyze each financial statement separately, they are all interrelated. The changes in Abbott Laboratories' assets and liabilities, for example, are also reflected in the revenues and expenses on on Abbott Laboratories' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue156.6 M148.8 M
Total Revenue44.3 B23.4 B
Cost Of Revenue19.7 B10.5 B
Stock Based Compensation To Revenue 0.01  0.01 
Sales General And Administrative To Revenue 0.25  0.22 
Research And Ddevelopement To Revenue 0.07  0.09 
Capex To Revenue 0.05  0.07 
Revenue Per Share 25.37  26.64 
Ebit Per Revenue 0.18  0.21 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Abbott Stock Analysis

When running Abbott Laboratories' price analysis, check to measure Abbott Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbott Laboratories is operating at the current time. Most of Abbott Laboratories' value examination focuses on studying past and present price action to predict the probability of Abbott Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abbott Laboratories' price. Additionally, you may evaluate how the addition of Abbott Laboratories to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY